The Doctors of Distinction Golf Invitational brings together New York metro area’s physicians and business leaders for a day of golf on an exceptional area course. This event raises funds for the American Cancer Society’s life-saving mission.
Emeline Aviki, MD, MBA is a nationally recognized gynecologic oncologist, physician executive, and leader in advancing innovative, patient-centered cancer care. She serves as Associate Chief Clinical Officer for Clinical Affairs and Ambulatory Strategy at NYU Langone Health, where she leads system-wide initiatives to expand access to care, optimize clinical operations, improve quality and patient experience, and advance clinical integration across specialties and regions. Previously, she served as Deputy Chief Clinical Officer for the Perlmutter Cancer Center, where she led multidisciplinary initiatives to strengthen cancer care delivery and improve access across the cancer network. She also maintains an active clinical practice caring for women with gynecologic cancers across Long Island.
Dr. Aviki earned her Doctor of Medicine and Master of Business Administration degrees from Duke University. She completed her residency in obstetrics and gynecology through the Harvard Combined Program at Massachusetts General Hospital and Brigham and Women’s Hospital, followed by a fellowship in gynecologic oncology at Memorial Sloan Kettering Cancer Center.
A recognized leader in value-based oncology care, Dr. Aviki has dedicated her career to improving quality while reducing barriers to treatment. At Memorial Sloan Kettering, she pioneered a comprehensive program to identify and address financial toxicity for patients with cancer. More recently, she has led the development of innovative fertility preservation programs at NYU Langone Health, expanding access to state-of-the-art fertility preservation options for patients across the health system.
Dr. Aviki serves as Secretary-Treasurer of the Society of Gynecologic Oncology, is a member of the editorial board of the Journal of Clinical Oncology: Oncology Practice, and has authored more than 80 peer-reviewed publications focused on value-based cancer care, healthcare delivery, and quality improvement.
Through her clinical expertise, visionary leadership, and commitment to innovation, Dr. Aviki continues to shape the future of cancer care by improving access, advancing quality, and ensuring patients receive compassionate, equitable care. The American Cancer Society is proud to honor Dr. Aviki as a Doctor of Distinction in recognition of her outstanding contributions to oncology and her dedication to improving the lives of patients with cancer.
Dr. Randall Feingold is a founding partner of New York Breast Reconstruction and Aesthetic Plastic Surgery (NYBRA), Clinical Associate Professor of Surgery at the Zucker School of Medicine at Hofstra/Northwell, and Director of the Division of Plastic Surgery at St. Francis Hospital in Roslyn. With over 30 years of experience in microsurgery, Dr. Feingold is a recognized expert in breast reconstruction and specializes in aesthetic surgery of the face, nose, breast, and body, including explant surgery.
In addition to his esteemed medical career, Dr. Feingold has devoted nearly two decades to our mission and has become an integral part of the American Cancer Society, currently serving on the ACS Long Island Board. He founded the Doctors of Distinction Golf Invitational 19 years ago and has served as Event Chair ever since. In addition, Dr. Feingold was the recipient of the Eugene O’Kelly Award in Philanthropy for his distinguished service to the American Cancer Society at the 2024 Financial Services Cares Gala in Manhattan. His tireless efforts on the frontlines of our mission ensures that everyone has an equal opportunity to prevent, detect, treat, and survive cancer.
For more than 10 decades, the American Cancer Society has been dedicated to pursuing better outcomes for every cancer, every life. Today, more people are surviving cancer than ever before, but there is still work to be done. Join us, support us, and help us end cancer as we know it, for everyone.
towards cancer research
winning scientists received research funding
through all patient support initiatives in 2024
